Delcath Systems, Inc. (DCTH) belongs to the “Healthcare” sector with an industry focus on “Drug Delivery”, with Dr. Roger G. Stoll Ph.D. as Exec. Chairman.
The company has been one of the biggest innovators in “Drug Delivery” employing approximately 43 full time employees.
- The stock subtracted in the prior trading session by -2.62%, closing at the stock price of $0.11.
- Currently, the market capitalization of Delcath Systems, Inc. (DCTH) is 53.75 Million.
- DCTH has a 1-year high price of $ 4.31 and 1-year low price of $0.01.
- The number of shares currently held by investors is 499.03 Million.
- The number of shares traded in the last trading session was 28.28 Million.
The company reported an impressive total revenue of 1.99 Million in the last fiscal year.
If you look at the company’s income statement over the past years, you will see that the company is constantly posting gross profit: In 2014, DCTH earned gross profit of 780000, in 2015 1.28 Million gross profit, while in 2016 Delcath Systems, Inc. (DCTH) produced 1.44 Million profit.
Currently the shares of Delcath Systems, Inc. (DCTH) has a trading volume of 28.28 Million shares, with an average trading volume of 35610 shares – with shares dropping to a 52 week low of $0.01, and the company’s shares hitting a 52 week high of $ 4.31.
Looking at the current price of the stock and the 52 week high and low, it suggests that the stock is likely to go Up in the future.
Earnings per share (EPS) breaks down the profitability of the company on a single share basis, and for Delcath Systems, Inc. the EPS stands at -0.66 for the previous quarter, while the analysts predicted the EPS of the stock to be -3.29, suggesting the stock exceeded the analysts’ expectations.
Another critical number in evaluating a stock is P/E or the price to earnings ratio.
The TTM operating margin is 0%. The return on invested capital at -139.3%, which is good, compared to its peers.
The Free Cash Flow or FCF margin is 0%, which means that the business has healthy reserve funds for contingencies that may arise.
Stock is currently moving with a negative distance from the 200 day simple moving average of approximately -73.24%, and has a poor year to date (YTD) performance of -88.29% which means the stock is constantly subtracting to its value from the previous fiscal year end price.
The target price for Delcath Systems, Inc. (DCTH) is $16/share according to the consensus of analysts working on the stock, with an expected EPS of $0/share for the current quarter.